🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Melphalan with a hepatic delivery system demonstrated a favorable benefit-risk profile compared with best alternative care in a small cohort of patients with unresectable metastatic uveal melanoma. #melsm | Jonathan Zager, MD hubs.li/Q03l6GfQ0

May Issue: Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with #Melanoma . Roger Olofsson Bagge Cristina O’Donoghue J. Harrison Howard, MD MarkFariesMD Jonathan Zager, MD rdcu.be/ekVZg Dorian Y. García-Ortega MD, MSc,PhD, FACS Syed A. Ahmad

Melphalan/Hepatic Delivery System Demonstrates Benefit over best alternative care in Uveal Melanoma cancernetwork.com/view/melphalan… via @CancerNetwork® Moffitt Cancer Center

Kicking off the #MoffittScientificSymposium, Moffitt CEO Patrick Hwu, MD Dr. Patrick Hwu welcomes 500+ attendees and highlights the importance of interdisciplinary sciences uniting to drive our mission: preventing and curing cancer.

Incredible to learn from Dr. Hwu, Dr. Lu, and Dr. Freeman on how Moffitt is using AI to revolutionize cancer care today at tonight talk. Grateful—and proud—to work alongside such visionary leaders. Dr. Freeman’s CAR T storytelling was next-level!!! #CancerResearch #AIpower

We’re grateful to be nominated as one of the Best of the Best in Tampa Bay! From diagnosis through survivorship, we’re honored to walk beside every individual and family with world-class care and compassion. Every vote is a voice of support for our patients, survivors, and

Thank you Avant Garde for this honor. certificates.avantgardehealth.com/credentials/d7…. Moffitt Cancer Center thank you for the resources and support that allow me to make this possible.

Registration is now OPEN for the SSO 2025 SurgOnc Race for Research! The race officially kicks off on June 1st, so now is a great time to gather a team and explore the event webpage. Register: runsignup.com/Race/IL/Rosemo…

Moffitt GME Graduation - 46 graduates - congrats to all of you! Good luck and thank you for the years of incredible patient care, ground breaking research and being an integral part of the team. Moffitt Cancer Center

Congrats again!! Great group of accomplished doctors!

Honored to host Russell S. Berman Fox Chase Surgical Oncology for our inaugural endowed lecture in the Department of Surgery Fox Chase Cancer Center learning from the ultimate #Mentor Society of Surgical Oncology American College of Surgeons Temple Health Weill Cornell Medicine American Board of Surgery Assoc4AcademicSurgery

We are thrilled to welcome our newest class of fellows in the CGSO match today. Welcome to the Moffitt Cancer Center family! Society of Surgical Oncology

Congrats Jeffrey Farma !

#FollowFriday Meet Robert Wenham, MD (Robert Wenham), chair of gynecological oncology at Moffitt. He specializes in complex cancers and is a leader in pelvic exenteration surgery, offering hope for hard-to-treat cases. A strong advocate for research and clinical trials, he’s

#FollowFriday Milijana Ugrenovic-Petrovic is the Director of Clinical Research Operations Moffitt Cancer Center. Go give her a follow Milijana Ugrenovic-Petrovic!

#AudioVisualAbstract : Hepatic and Overall Progression-Free Survival After #PercutaneousHepaticPerfusion (PHP) as First-Line or Second-Line Therapy for Metastatic #UvealMelanoma . Helana Ghali Jonathan Zager, MD rdcu.be/ewDz5 @Laleh_Melstrom Syed A. Ahmad

Proud to watch Moffitt continue to rise in rankings! #MoffittCancerCenter

Featured: Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with #Melanoma . Anne Huibers Roger Olofsson Bagge ow.ly/cK9350WyQ9P James Jakub Syed A. Ahmad

Another nice collaborative work by Roger Olofsson Bagge, Anne Huibers, Jonathan Zager, MD and the SLNWG. Large international database. Risk factors for ITM - the usual suspects. Going to need to firm up biomarkers beyond demographics and path, likely GEP + clinical factors to be actionable.

Congratulations Moffitt Cancer Center! Proud to be part of this mission.